Appointment sheet
Adenosquamous carcinoma of the cervix
Prepared with OnCo (onco.cc/prep/cervical-adenosquamous-carcinoma/). Orientation, not medical advice; your team knows your case.
My details
Name
Date of appointment
Hospital and clinician
Who is coming with me
What I know, what is unclear, changes to discuss
Saved in this browserWhat I know so far
What is unclear to me
Changes since last time
My questions
8 on the sheetNewly diagnosed
- 1.What is my exact diagnosis, stage, and grade, and which tests established them?
- 2.Which biomarkers have been tested on my tumour (for example p16 and HPV status, Both glandular and squamous components on histology, FIGO stage and tumour bulk, PD-L1 for recurrent disease), and what were the results?
- 3.Which subtype is my cancer, and does that change the recommended treatment?
- 4.Is germline (inherited) genetic testing recommended for me or my family?
All stages
- 5.For my situation (all stages), which of the standard options do you recommend and why?
- 6.Am I a candidate for Cisplatin, Pembrolizumab, Bevacizumab, and what side effects should I expect?
Any stage
- 7.Would a second opinion at a high-volume centre change anything, and can you help arrange it?
- 8.What supportive care (symptom control, nutrition, exercise, mental health, financial help) is available from the start?
The words I may hear
- HPV-positive (p16) head and neck cancer: Throat cancers caused by the human papillomavirus, identified by a p16 stain.
- Chemoradiation (chemoradiotherapy, CRT): Radiotherapy given at the same time as chemotherapy, which sensitises the cancer to radiation.
Tests and results to bring
Biomarker results to ask for: p16 and HPV status, Both glandular and squamous components on histology, FIGO stage and tumour bulk, PD-L1 for recurrent disease.
Bring copies of scan reports, pathology and blood results, and a list of every medicine and supplement.
The treatments I may be offered
- All stages: Treated as cervical cancer by stage: radical hysterectomy when early, cisplatin chemoradiation with brachytherapy when locally advanced, platinum with pembrolizumab or bevacizumab when recurrent. (Cervical cancer, Early cervical cancer and fertility-sparing surgery, Recurrent or metastatic cervical cancer, Cisplatin, Pembrolizumab, Bevacizumab, Brachytherapy)
From the standard of care recorded for this cancer; which apply depends on your stage and biomarkers. Ask which the team recommends and why.
Answers and next steps
Saved in this browserWhat I was told
Agreed next steps, dates and who to call